The employee benefits market is a model for innovation.

The changing landscape is creating an opportunity to transform not only how consumers receive and understand their healthcare, but how they use and pay for that care.

From passage of the ACA to the injection of digital health and technology companies into the ecosystem, the industry is grappling with how to improve the health of employee populations, while decreasing healthcare costs for employers.

In a world where transparency and innovation meet cost and regulatory challenges, employee benefits consultants must remain agile.

All Healthcare Items

Back Door Discounts
Healthcare In Transition | May. 16, 2019 | Employer sponsored insurance, Healthcare costs, Leader’s Edge, Pharmacy supply chain, Prescription Drug Pricing

The pharmacy supply chain is one of the most complex and opaque parts of the healthcare ecosystem. Co-pay discounts and other rebates may lower costs, but do not address the

Government Affairs Roundup: The Latest on Healthcare Policy
Healthcare In Transition | May. 16, 2019 | ACA, Access to Care, Employer sponsored insurance, Government Affairs, Healthcare, Healthcare costs, Healthcare data, Healthcare reform, Payment reform, Prescription Drug Pricing, Pricing transparency, Single Payer, state activity, Surprise Medical Billing, Technology

Surprise Medical Billing Broad bipartisan support from the Trump administration as well as Congress has created momentum around surprise medical billing. Earlier this week, the House Energy and Commerce Committee

How We’re Fighting Surprise Medical Billing
Healthcare In Transition | Apr. 18, 2019 | Healthcare

April 18, 2019 The Council has joined over 30 other employment-based trade groups to provide two letters on the issue of surprise medical billing to House leadership, and the chair

The Latest on Healthcare from our Government Affairs Duo
Healthcare In Transition, Video | Apr. 18, 2019 | ACA, Association health plans, Healthcare, Medicare, Prescription Drug Pricing

April 18, 2019 Joel Wood, SVP, Government Affairs and Joel Kopperud, VP, Government Affairs, give us the lowdown on AHPs, the ACA, Medicare for All and drug pricing—and what we can

An Update on Association Health Plans
Healthcare In Transition | Apr. 18, 2019 | Association health plans, Healthcare

April 18, 2019 In response to a federal district court decision to set aside portions of the DOL’s Association Health Plan (AHP) rule, a group of Republican senators, led by

Genetic Benefit (Leader’s Edge)
Healthcare In Transition | Mar. 21, 2019 | Access to Care, Employee Benefits, Employer sponsored insurance, Healthcare costs, Healthcare data & technology, Healthtech, Leader’s Edge, Quality

March 21, 2019 One in every two individuals born today will be diagnosed with cancer—a genetic disease—at some point during their lifetime. Nick Bellanca of Wamberg Genomic Advisors breaks down

Webinar: Tools You Can Use to Dig into National Prescription Drug Pricing
Council Brief, Healthcare In Transition, Webinar | Mar. 21, 2019 | Healthcare, Healthcare costs, Healthcare data, Healthcare data & technology, PBM, Pharmacy supply chain, Prescription Drug Pricing, Pricing transparency

March 21, 2019 The Council’s Katie Oberkircher spoke with Eric Pachman and Antonio Ciaccia, co-founders of 46Brooklyn—a prescription drug research firm—to demonstrate how to use the tools they’ve created to